Fuda Cancer Hospital
Fuda Cancer Hospital
China, Guangzhou
Gastroscopy with biopsy in China typically costs from $100 to $300. Total expenses depend on the clinic tier, city, and the use of intravenous sedation. Patients save about 91% compared to the US, where similar procedures cost $2,200 on average. Major medical hubs like Beijing, Shanghai, and Guangzhou offer specialized international departments for foreign patients.
Bookimed Expert Insight: Choosing a hospital with an integrated oncology center provides better value for suspicious findings. Clinics like Xiamen Humanity Hospital or Fuda Cancer Hospital offer on-site pathology and specialized tumor resection. This setup avoids separate booking fees for follow-up tests if a biopsy returns positive. Many international departments in Shanghai now offer bundled "painless" packages that combine the scan, anesthesia, and recovery room stay.
| China | Turkey | Austria | |
| Gastroscopy with biopsy | from $100 | from $150 | from $500 |
No hidden fees – just official clinic prices. Pay at the clinic for Gastroscopy with biopsy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Gastroscopy with biopsy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Gastroscopy with biopsy journey.
Dr. Sun Guangxi is a gastroenterologist at Shanghai Tongji Hospital. He has performed thousands of painless gastroscopy and colonoscopy procedures. He specializes in the early detection and minimally invasive treatment of digestive cancers. Dr. Sun is a member of the Chinese Medical Association’s Digestive Endoscopy Society.
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).
Dr. Zhang Rong Chun directs the gastroenterology department at Xiamen Humanity Hospital. He is a leading authority in digestive endoscopy and gastroscopy with biopsy.